GILD vs GRNQ · P/E 18, rev $7.80B vs rev $707.6K
Gilead Sciences Inc (GILD) versus GreenPro Capital Corp (GRNQ) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
GreenPro Capital Corp (GRNQ) is a consulting services company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported GRNQ revenue for 2026-06-30 was $707.6K. Net income was -$1.6M. Revenue was up 74.5% from 2026-03-31 to 2026-06-30. GRNQ currently screens at market cap $23.8M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. GRNQ currently screens at market cap $23.8M.
Not investment advice. Open the GILD and GRNQ stock pages for the full models.
Not investment advice.